Company / Working Capital
Relay Therapeutics, Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$552.7M
FY2025
5-year range
$552.7M / $955.8M
FY2021-FY2025
Trend
-27.1%
vs FY2024
Sector context
#81 of 213
Health Care
What the data says
At $553M, Relay Therapeutics, Inc.'s working capital ranks #81 of 213 in the Health Care sector. Working Capital has fluctuated over the past 7 years, ranging from $349M in FY2019 to $956M in FY2022.
Based on SEC 10-K filings.
$553M in FY2025 with a 5-year CAGR of -6.1%.
Declined from $740M to $553M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -16.7%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Sector benchmark
#81 of 213 in Health CareTop 38% of 213This company $552.7M Sector average $934.6M
▼
-40.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.1%, indicating a declining trend.
- In FY2025, working capital decreased 27.1% year-over-year.
- Ranks #81 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $552.7M | -27.1% |
| FY2024 | $758.5M | +2.5% |
| FY2023 | $739.8M | -22.6% |
| FY2022 | $955.8M | +0.4% |
| FY2021 | $951.9M | +25.8% |
| FY2020 | $756.5M | +117.0% |
| FY2019 | $348.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026